跳至主要内容
临床试验/NCT00894517
NCT00894517已完成1 期

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

Allergan0 个研究点目标入组 61 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Allergan
入组人数
61
主要终点
Percent Change in Total Sperm Count Per Ejaculate

研究概览

简要总结

This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Symptoms due to an enlarged prostate
  • Able to provide semen samples at required visits.

排除标准

  • Previous use of any botulinum toxin for the treatment of any urological condition
  • History of vasectomy
  • History of undescended testicles or testicular trauma
  • Subject who has not ejaculated for greater than 1 year
  • History of prostate infection or any sexually transmitted disease, such as gonorrhea, within the previous 12 months
  • History of bladder stones
  • History of cancer in the prostate, testicles, or bladder
  • Previous use of chemotherapy for cancer treatment
  • History of urinary incontinence
  • Previous prostate surgery

研究组 & 干预措施

Botulinum Toxin Type A

Experimental

OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1.

干预措施: Botulinum Toxin Type A (Biological)

Placebo (saline)

Placebo Comparator

Placebo (saline) injected into the prostate on Day 1.

干预措施: Placebo (saline) (Drug)

结局指标

主要结局

Percent Change in Total Sperm Count Per Ejaculate

时间窗: Baseline, Week 12

Sperm count per ejaculate was calculated based on the average of two semen samples collected 2 to 5 days apart at Baseline and at Week 12. Ejaculatory volume and sperm concentration were used to determine the total sperm count per ejaculate. A positive percent change from Baseline indicated improvement.

次要结局

  • Change From Baseline in Ejaculatory Volume(Baseline, Week 12)
  • Change From Baseline in Total Sperm Motility(Baseline, Week 12)
  • Change From Baseline in Log Transformed Sperm Concentration(Baseline, Week 12)
  • Change From Baseline in Normal Sperm Morphology(Baseline, Week 12)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验